CS Diagnostics Corp. (CSDX)
CS Diagnostics Corp. reported revenue of 23.1K USD for the quarter ending 30 September 2025.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Amounts in USD.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in USD.
| Figure | Period | Amount | Year on year |
|---|
| Revenue |
Q3 '25 · ending 30 September 2025 |
23.1K |
— |
| Operating Income |
Q3 '25 · ending 30 September 2025 |
-182 |
— |
| Net Income |
Q3 '25 · ending 30 September 2025 |
-182 |
— |
| Shares Outstanding |
Q3 '25 · ending 30 September 2025 |
137.4M |
— |
Every period
Revenue Quarterly
| Period | Ending | Revenue |
|---|
| Q3 '25 | 2025-09-30 | 23.1K |
|---|
| Q3 '24 | 2024-09-30 | 8K |
|---|
Operating Income Quarterly
| Period | Ending | Operating Income |
|---|
| Q3 '25 | 2025-09-30 | -182 |
|---|
| Q3 '24 | 2024-09-30 | 536 |
|---|
Net Income Quarterly
| Period | Ending | Net Income |
|---|
| Q3 '25 | 2025-09-30 | -182 |
|---|
| Q3 '24 | 2024-09-30 | 536 |
|---|
Shares Outstanding Quarterly
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
| Period | Ending | Shares Outstanding |
|---|
| Q3 '25 | 2025-09-30 | 137.4M |
|---|
| Q3 '24 | 2024-09-30 | 129.8M |
|---|